Search results

Measurement of factor X (FX or stuart factor) activity in human citrated plasma using a clotting method, triggered with calcium thromboplastin. For any in vitro protocol or research study where a source of human FX deficient plasma is required

Measurement of actor VIII (FVIII) activity in human citrated plasma using a clotting method, in the presence of cephalin, activator and calcium (aPTT reagent). For any in vitro protocol or research study where a source of human FVIII deficient plasma is required.

Quality control of clotting assays proposed for measuring argatroban concentrations in plasma (especially ref. CK002K, CK002L).

Quality control titrated and optimized for anti-IIa colorimetric assays (HEMOCLOT Thrombin Inhibitors: ref. CK002K/CK002L).

Quality control titrated and optimized for anti-IIa colorimetric assays (HEMOCLOT Thrombin Inhibitors: ref. CK002K/CK002L).

Calibrating the assays of argatroban using clotting anti-IIa methods, especially when the HEMOCLOT Thrombin Inhibitors kit (ref. CK002K, CK002L) is used, with the low range protocol.

Quantitative measurement of dabigatran, and anti-thrombin activities in plasma (e.g. Dabigatran Plasma Calibrator (ref. 222801), Dabigatran Control Plasma (ref. 224701), Argatroban Plasma Calibrator (ref. SC030K), Argatroban Control Plasma (ref. SC035K)).

Quantitative measurement of dabigatran, and anti-thrombin activities in plasma (e.g. Dabigatran Plasma Calibrator (ref. 222801), Dabigatran Control Plasma (ref. 224701), Argatroban Plasma Calibrator (ref. SC030K), Argatroban Control Plasma (ref. SC035K).

CRYOcheck CorPacTM consists of 30 individual vials containing human plasma with distinct prothrombin time (PT), activated partial thromboplastin time (aPTT) and fibrinogen profiles spanning the normal and pathological range.

Normal control for prothrombin time (PT) and activated partial thromboplastin time (aPTT) assays. May also be used as an alternative to in-house collected normal plasma pools.